Catalio Capital Management, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $477 Billion distributed in 40 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $42B, Bridge Bio Pharma, Inc. with a value of $40.1B, Soleno Therapeutics Inc with a value of $34.3B, Ascendis Pharma A/S with a value of $31.1B, and Intuitive Surgical Inc with a value of $30.8B.

Examining the 13F form we can see an increase of $65.8B in the current position value, from $411B to 477B.

Catalio Capital Management, LP is based out at New York, NY

Below you can find more details about Catalio Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $477 Billion
Healthcare: $394 Billion

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 40
  • Current Value $477 Billion
  • Prior Value $411 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 13 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 13 stocks
Track This Portfolio

Track Catalio Capital Management, LP Portfolio

Follow Catalio Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalio Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Catalio Capital Management, LP with notifications on news.